4 assets in Diarrheal Disease

Therapeutic assets addressing Diarrheal Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Loperamide Diarrheal Disease	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P3	BB (66)
Salovum Diarrheal Disease	Henrik Lindman	P3	B (60)
Mesalamine Diarrheal Disease	AHS Cancer Control Alberta	P2	CCC (53)